Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease

Arthritis and Rheumatism

Volumn 46, Issue 12, 2002, Pages 3388-3389

  Iwamoto, Masahiro ^a   Nara, Hiroyuki ^a   Hirata, Daisuke ^a   Minota, Seiji ^a   Nishimoto, Norihiro ^b   Yoshizaki, Kazuyuki ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; BETAMETHASONE; C REACTIVE PROTEIN; HUMANIZED MONOCLONAL INTERLEUKIN 6 RECEPTOR ANTIBODY; INDOMETACIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; RECEPTORS, INTERLEUKIN-6; STILL'S DISEASE, ADULT-ONSET;

EID: 0036898472     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10620     Document Type: Article

References (5)

1. Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971;30: 121-33.
2. Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y, et al. Elevated serum interleukin 6, interferon-γ, and tumor necrosis factor-α, levels in patients with adult Still's disease [letter]. J Rheumatol 1998;25:396-8.
3. Scheinberg MA, Chapira E, Fernandes ML, Hubscher O. Interleukin 6: A possible marker of disease activity in adult onset Still's disease. Clin Exp Rheumatol 1996;14:653-5.
4. Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis 2000;59 Suppl 1:i21-7.
5. Yamaguchi M, Ota A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwazaki H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.